The downgrade is a result of an analytic error from S&P that resulted from misunderstanding the risk associated with the defined benefit plan LMC participates in.
“In particular, we failed to incorporate into our analysis the appropriate budgetary uncertainty and financial profile risk considering the ongoing weak funded status of SCRS and the increasing employer contributions expected over the next several years,” said S&P credit analyst Patrick Zagar. “This downgrade reflects the incorporation of those risks into our analysis.”
The outlook is stable.
More articles on healthcare finance:
CMS miscalculated MIPS payment adjustments: 4 things to know
Memorial Sloan Kettering shifts fundraising focus as problems mount
CHS could face cash crunch after $262M settlement, Moody’s warns
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
